RXR – centralny regulator wielu ścieżek sygnałowych w organizmie

[1]Sladek F.M.: What are nuclear receptor ligands? Mol. Cell. Endocrinol., 2011; 334: 3-13Sladek F.M. What are nuclear receptor ligands? Mol Cell. Endocrinol 2011 334 3 1310.1016/j.mce.2010.06.018Search in Google Scholar

[2]Młynarczuk J., Rękawiecki R.: The role of the orphan receptor SF-1 in the development and function of the ovary. Reprod. Biol., 2010; 10: 177-193Młynarczuk J. Rękawiecki R. The role of the orphan receptor SF-1 in the development and function of the ovary Reprod. Biol 2010 10 177 19310.1016/S1642-431X(12)60039-4Search in Google Scholar

[3]Sánchez-Martínez R., Castillo A.I., Steinmeyer A., Aranda A.: The retinoid X receptor ligand restores defective signalling by the vitamin D receptor. EMBO Rep., 2006; 7: 1030-1034Sánchez-Martínez R. Castillo A.I. Steinmeyer A. Aranda A. The retinoid X receptor ligand restores defective signalling by the vitamin D receptor EMBO Rep 2006 7 1030 103410.1038/sj.embor.7400776Search in Google Scholar

[4]Lefebvre P., Benomar Y., Staels B.: Retinoid X receptors: Common heterodimerization partners with distinct functions. Trends Endocrinol. Metab., 2010; 21: 676-683Lefebvre P. Benomar Y. Staels B. Retinoid X receptors: Common heterodimerization partners with distinct functions Trends Endocrinol. Metab 2010 21 676 68310.1016/j.tem.2010.06.009Search in Google Scholar

[5]Skerrett R., Malm T., Landreth G.: Nuclear receptors in neurodegenerative diseases. Neurobiol. Dis., 2014; 72: 104-116Skerrett R. Malm T. Landreth G. Nuclear receptors in neurodegenerative diseases Neurobiol. Dis 2014 72 104 11610.1016/j.nbd.2014.05.019Search in Google Scholar

[6]Mangelsdorf D.J., Ong E.S., Dyck J.A., Evans R.M.: Nuclear receptor that identifies a novel retinoic acid response pathway. Nature, 1990; 345: 224-229Mangelsdorf D.J. Ong E.S. Dyck J.A. Evans R.M. Nuclear receptor that identifies a novel retinoic acid response pathway Nature 1990 345 224 22910.1038/345224a0Search in Google Scholar

[7]Heyman R.A., Mangelsdorf D.J., Dyck J.A., Stein R.B., Eichele G., Evans R.M., Thaller C.: 9-cis retinoic acid is a high affinity ligand for the retinoid X receptor. Cell, 1992; 68: 397-406Heyman R.A. Mangelsdorf D.J. Dyck J.A. Stein R.B. Eichele G. Evans R.M. Thaller C. 9-cis retinoic acid is a high affinity ligand for the retinoid X receptor Cell 1992 68 397 40610.1016/0092-8674(92)90479-VSearch in Google Scholar

[8]Mangelsdorf D.J., Borgmeyer U., Heyman R.A., Zhou J.Y., Ong E.S., Oro A.E., Kakizuka A., Evans R.M.: Characterization of three RXR genes that mediate the action of 9-cis retinoic acid. Genes Dev., 1992; 6: 329-344Mangelsdorf D.J. Borgmeyer U. Heyman R.A. Zhou J.Y. Ong E.S. Oro A.E. Kakizuka A. Evans R.M. Characterization of three RXR genes that mediate the action of 9-cis retinoic acid Genes Dev 1992 6 329 34410.1101/gad.6.3.329Search in Google Scholar

[9]Rowe A.: Retinoid X receptors. Int. J. Biochem. Cell Biol., 1997; 29: 275-278Rowe A. Retinoid X receptors Int. J. Biochem. Cell Biol 1997 29 275 27810.1016/S1357-2725(96)00101-XSearch in Google Scholar

[10]Aranda A., Pascual A.: Nuclear hormone receptors and gene expression. Physiol. Rev., 2001; 81: 1269-1304Aranda A. Pascual A. Nuclear hormone receptors and gene expression Physiol. Rev 2001 81 1269 130410.1152/physrev.2001.81.3.126911427696Search in Google Scholar

[11]McKenna N.J., O’Malley B.W.: Combinatorial control of gene expression by nuclear receptors and coregulators. Cell, 2002; 108: 465-474McKenna N.J. O’Malley B.W. Combinatorial control of gene expression by nuclear receptors and coregulators Cell 2002 108 465 47410.1016/S0092-8674(02)00641-4Search in Google Scholar

[12]Hanish B.J., Hackney Price J.F., Kaneko I., Ma N., van der Vaart A., Wagner C.E., Jurutka P.W., Marshall P.A.: A novel gene expression analytics-based approach to structure aided design of rexinoids for development as next-generation cancer therapeutics. Steroids, 2018; 135: 36-49Hanish B.J. Hackney Price J.F. Kaneko I. Ma N. van der Vaart A. Wagner C.E. Jurutka P.W. Marshall P.A. A novel gene expression analytics-based approach to structure aided design of rexinoids for development as next-generation cancer therapeutics Steroids 2018 135 36 4910.1016/j.steroids.2018.04.009Search in Google Scholar

[13]Yasmin R., Yeung K.T., Chung R.H., Gaczynska M.E., Osmulski P.A., Noy N.: DNA-looping by RXR tetramers permits transcriptional regulation “at a distance”. J. Mol. Biol., 2004; 343: 327-338Yasmin R. Yeung K.T. Chung R.H. Gaczynska M.E. Osmulski P.A. Noy N. DNA-looping by RXR tetramers permits transcriptional regulation “at a distance” J. Mol. Biol 2004 343 327 33810.1016/j.jmb.2004.08.070Search in Google Scholar

[14]Shulman A.I., Larson C., Mangelsdorf D.J., Ranganathan R.: Structural determinants of allosteric ligand activation in RXR heterodimers. Cell, 2004; 116: 417-429Shulman A.I. Larson C. Mangelsdorf D.J. Ranganathan R. Structural determinants of allosteric ligand activation in RXR heterodimers Cell 2004 116 417 42910.1016/S0092-8674(04)00119-9Search in Google Scholar

[15]Westin S., Kurokawa R., Nolte R.T., Wisely G.B., McInerney E.M., Rose D.W., Milburn M.V., Rosenfeld M.G., Glass C.K.: Interactions controlling the assembly of nuclear-receptor heterodimers and co-activators. Nature, 1998; 395: 199-202Westin S. Kurokawa R. Nolte R.T. Wisely G.B. McInerney E.M. Rose D.W. Milburn M.V. Rosenfeld M.G. Glass C.K. Interactions controlling the assembly of nuclear-receptor heterodimers and co-activators Nature 1998 395 199 20210.1038/260409744281Search in Google Scholar

[16]Germain P., Iyer J., Zechel C., Gronemeyer H.: Co-regulator recruitment and the mechanism of retinoic acid receptor synergy. Nature, 2002; 415: 187-192Germain P. Iyer J. Zechel C. Gronemeyer H. Co-regulator recruitment and the mechanism of retinoic acid receptor synergy Nature 2002 415 187 19210.1038/415187a11805839Search in Google Scholar

[17]Zhang X.K., Lehmann J., Hoffmann B., Dawson M.I., Cameron J., Graupner G., Hermann T., Tran P., Pfahl M.: Homodimer formation of retinoid X receptor induced by 9-cis retinoic acid. Nature, 1992; 358: 587-591Zhang X.K. Lehmann J. Hoffmann B. Dawson M.I. Cameron J. Graupner G. Hermann T. Tran P. Pfahl M. Homodimer formation of retinoid X receptor induced by 9-cis retinoic acid Nature 1992 358 587 59110.1038/358587a01323763Search in Google Scholar

[18]Kersten S., Kelleher D., Chambon P., Gronemeyer H., Noy N.: Retinoid X receptor alpha forms tetramers in solution. Proc. Natl. Acad. Sci. USA, 1995; 92: 8645-8649Kersten S. Kelleher D. Chambon P. Gronemeyer H. Noy N. Retinoid X receptor alpha forms tetramers in solution Proc. Natl. Acad. Sci. USA 1995 92 8645 864910.1073/pnas.92.19.8645410237567990Search in Google Scholar

[19]Tanaka T., Suh K.S., Lo A.M., De Luca L.M.: p21WAF1/CIP1 is a common transcriptional target of retinoid receptors: Pleiotropic regulatory mechanism through retinoic acid receptor (RAR)/retinoid X receptor (RXR) heterodimer and RXR/RXR homodimer. J. Biol. Chem., 2007; 282: 29987-29997Tanaka T. Suh K.S. Lo A.M. De Luca L.M. p21WAF1/CIP1 is a common transcriptional target of retinoid receptors: Pleiotropic regulatory mechanism through retinoic acid receptor (RAR)/retinoid X receptor (RXR) heterodimer and RXR/RXR homodimer J. Biol. Chem 2007 282 29987 2999710.1074/jbc.M70170020017656367Search in Google Scholar

[20]Núñez V., Alameda D., Rico D., Mota R., Gonzalo P., Cedenilla M., Fischer T., Boscá L., Glass C.K., Arroyo A.G., Ricote M.: Retinoid X receptor alpha controls innate inflammatory responses through the up-regulation of chemokine expression. Proc. Natl. Acad. Sci. USA, 2010; 107: 10626-10631Núñez V. Alameda D. Rico D. Mota R. Gonzalo P. Cedenilla M. Fischer T. Boscá L. Glass C.K. Arroyo A.G. Ricote M. Retinoid X receptor alpha controls innate inflammatory responses through the up-regulation of chemokine expression Proc. Natl. Acad. Sci. USA 2010 107 10626 1063110.1073/pnas.0913545107289083120498053Search in Google Scholar

[21]Chen H., Privalsky M.L.: Cooperative formation of high-order oligomers by retinoid X receptors: An unexpected mode of DNA recognition. Proc. Natl. Acad. Sci. USA, 1995; 92: 422-426Chen H. Privalsky M.L. Cooperative formation of high-order oligomers by retinoid X receptors: An unexpected mode of DNA recognition Proc. Natl. Acad. Sci. USA 1995 92 422 42610.1073/pnas.92.2.422Search in Google Scholar

[22]Mark M., Ghyselinck N.B., Chambon P.: Function of retinoid nuclear receptors: Lessons from genetic and pharmacological dissections of the retinoic acid signaling pathway during mouse embryogenesis. Annu. Rev. Pharmacol. Toxicol., 2006; 46: 451-480Mark M. Ghyselinck N.B. Chambon P. Function of retinoid nuclear receptors: Lessons from genetic and pharmacological dissections of the retinoic acid signaling pathway during mouse embryogenesis Annu. Rev. Pharmacol. Toxicol 2006 46 451 48010.1146/annurev.pharmtox.46.120604.141156Search in Google Scholar

[23]Chiang J.Y.: Bile acid regulation of gene expression: Roles of nuclear hormone receptors. Endocr. Rev., 2002; 23: 443-463Chiang J.Y. Bile acid regulation of gene expression: Roles of nuclear hormone receptors Endocr. Rev 2002 23 443 46310.1210/er.2000-0035Search in Google Scholar

[24]Sadasivuni M.K., Reddy B.M., Singh J., Anup M.O., Sunil V., Lakshmi M.N., Yogeshwari S., Chacko S.K., Pooja T.L., Dandu A., Harish C., Gopala A.S., Pratibha S., Naveenkumar B.S., Pallavi P.M. i wsp.: CNX-013-B2, a unique pan tissue acting rexinoid, modulates several nuclear receptors and controls multiple risk factors of the metabolic syndrome without risk of hypertriglyceridemia, hepatomegaly and body weight gain in animal models. Diabetol. Metab. Syndr., 2014; 6: 83Sadasivuni M.K. Reddy B.M. Singh J. Anup M.O. Sunil V. Lakshmi M.N. Yogeshwari S. Chacko S.K. Pooja T.L. Dandu A. Harish C. Gopala A.S. Pratibha S. Naveenkumar B.S. Pallavi P.M. i wsp CNX-013-B2, a unique pan tissue acting rexinoid, modulates several nuclear receptors and controls multiple risk factors of the metabolic syndrome without risk of hypertriglyceridemia, hepatomegaly and body weight gain in animal models Diabetol. Metab. Syndr 2014 6 8310.1186/1758-5996-6-83Search in Google Scholar

[25]Széles L., Póliska S., Nagy G., Szatmari I., Szanto A., Pap A., Lindstedt M., Santegoets S.J., Rühl R., Dezsö B., Nagy L.: Research resource: Transcriptome profiling of genes regulated by RXR and its permissive and nonpermissive partners in differentiating monocyte-derived dendritic cells. Mol. Endocrinol., 2010; 24: 2218-2231Széles L. Póliska S. Nagy G. Szatmari I. Szanto A. Pap A. Lindstedt M. Santegoets S.J. Rühl R. Dezsö B. Nagy L. Research resource: Transcriptome profiling of genes regulated by RXR and its permissive and nonpermissive partners in differentiating monocyte-derived dendritic cells Mol. Endocrinol 2010 24 2218 223110.1210/me.2010-0215Search in Google Scholar

[26]Kim H.T., Kong G., DeNardo D., Li Y., Uray I., Pal S., Mohsin S., Hilsenbeck S.G., Bissonnette R., Lamph W.W., Johnson K., Brown P.H.: Identification of biomarkers modulated by the rexinoid LGD1069 (Bexarotene) in human breast cells using oligonucleotide arrays. Cancer Res., 2006; 66: 12009-12018Kim H.T. Kong G. DeNardo D. Li Y. Uray I. Pal S. Mohsin S. Hilsenbeck S.G. Bissonnette R. Lamph W.W. Johnson K. Brown P.H. Identification of biomarkers modulated by the rexinoid LGD1069 (Bexarotene) in human breast cells using oligonucleotide arrays Cancer Res 2006 66 12009 1201810.1158/0008-5472.CAN-05-2515Search in Google Scholar

[27]Prüfer K., Barsony J.: Retinoid X receptor dominates the nuclear import and export of the unliganded vitamin D receptor. Mol. Endocrinol., 2002; 16: 1738-1751Prüfer K. Barsony J. Retinoid X receptor dominates the nuclear import and export of the unliganded vitamin D receptor Mol. Endocrinol 2002 16 1738 175110.1210/me.2001-0345Search in Google Scholar

[28]Chambon P.: A decade of molecular biology of retinoic acid receptors. FASEB J., 1996; 10: 940-954Chambon P. A decade of molecular biology of retinoic acid receptors FASEB J 1996 10 940 95410.1096/fasebj.10.9.8801176Search in Google Scholar

[29]Rochette-Egly C.: Nuclear receptors: Integration of multiple signalling pathways through phosphorylation. Cell. Signal., 2003; 15: 355-366Rochette-Egly C. Nuclear receptors: Integration of multiple signalling pathways through phosphorylation Cell. Signal 2003 15 355 36610.1016/S0898-6568(02)00115-8Search in Google Scholar

[30]Wärnmark A., Treuter E., Wright A.P., Gustafsson J.A.: Activation functions 1 and 2 of nuclear receptors: Molecular strategies for transcriptional activation. Mol. Endocrinol., 2003; 17: 1901-1909Wärnmark A. Treuter E. Wright A.P. Gustafsson J.A. Activation functions 1 and 2 of nuclear receptors: Molecular strategies for transcriptional activation Mol. Endocrinol 2003 17 1901 190910.1210/me.2002-038412893880Search in Google Scholar

[31]Kumar R., Thompson E.B.: Transactivation functions of the Nterminal domains of nuclear hormone receptors: Protein folding and coactivator interactions. Mol. Endocrinol., 2003; 17: 1-10Kumar R. Thompson E.B. Transactivation functions of the Nterminal domains of nuclear hormone receptors: Protein folding and coactivator interactions Mol. Endocrinol 2003 17 1 1010.1210/me.2002-025812511601Search in Google Scholar

[32]Fernandez E.J.: Allosteric pathways in nuclear receptors – Potential targets for drug design. Pharmacol. Ther., 2018; 183: 152-159Fernandez E.J. Allosteric pathways in nuclear receptors – Potential targets for drug design Pharmacol. Ther 2018 183 152 15910.1016/j.pharmthera.2017.10.014581700329080700Search in Google Scholar

[33]Andersen R.J., Mawji N.R., Wang J., Wang G., Haile S., Myung J.K., Watt K., Tam T., Yang Y.C., Bañuelos C.A., Williams D.E., McEwan I.J., Wang Y., Sadar M.D.: Regression of castrate-recurrent prostate cancer by a small-molecule inhibitor of the aminoterminus domain of the androgen receptor. Cancer Cell, 2010; 17: 535-546Andersen R.J. Mawji N.R. Wang J. Wang G. Haile S. Myung J.K. Watt K. Tam T. Yang Y.C. Bañuelos C.A. Williams D.E. McEwan I.J. Wang Y. Sadar M.D. Regression of castrate-recurrent prostate cancer by a small-molecule inhibitor of the aminoterminus domain of the androgen receptor Cancer Cell 2010 17 535 54610.1016/j.ccr.2010.04.02720541699Search in Google Scholar

[34]Anbalagan M., Huderson B., Murphy L., Rowan B.G.: Post-translational modifications of nuclear receptors and human disease. Nucl. Recept. Signal., 2012; 10: e001Anbalagan M. Huderson B. Murphy L. Rowan B.G. Post-translational modifications of nuclear receptors and human disease Nucl. Recept. Signal 2012 10 e00110.1621/nrs.10001330907522438791Search in Google Scholar

[35]Ahuja H.S., Szanto A., Nagy L., Davies P.J.: The retinoid X receptor and its ligands: Versatile regulators of metabolic function, cell differentiation and cell death. J. Biol. Regul. Homeost. Agents, 2003; 17: 29-45Ahuja H.S. Szanto A. Nagy L. Davies P.J. The retinoid X receptor and its ligands: Versatile regulators of metabolic function, cell differentiation and cell death J. Biol. Regul. Homeost. Agents 2003 17 29 45Search in Google Scholar

[36]Egea P.F., Mitschler A., Moras D.: Molecular recognition of agonist ligands by RXRs. Mol. Endocrinol., 2002; 16: 987-997Egea P.F. Mitschler A. Moras D. Molecular recognition of agonist ligands by RXRs Mol. Endocrinol 2002 16 987 99710.1210/mend.16.5.082311981034Search in Google Scholar

[37]Adam-Stitah S., Penna L., Chambon P., Rochette-Egly C.: Hyperphosphorylation of the retinoid X receptor α by activated c-Jun NH2-terminal kinases. J. Biol. Chem., 1999; 274: 18932-18941Adam-Stitah S. Penna L. Chambon P. Rochette-Egly C. Hyperphosphorylation of the retinoid X receptor α by activated c-Jun NH2-terminal kinases J. Biol. Chem 1999 274 18932 1894110.1074/jbc.274.27.1893210383391Search in Google Scholar

[38]Bastien J., Adam-Stitah S., Plassat J.L., Chambon P., Rochette-Egly C.: The phosphorylation site located in the A region of retinoic X receptor α is required for the antiproliferative effect of retinoic acid (RA) and the activation of RA target genes in F9 cells. J. Biol. Chem., 2002; 277: 28683-28689Bastien J. Adam-Stitah S. Plassat J.L. Chambon P. Rochette-Egly C. The phosphorylation site located in the A region of retinoic X receptor α is required for the antiproliferative effect of retinoic acid (RA) and the activation of RA target genes in F9 cells J. Biol. Chem 2002 277 28683 2868910.1074/jbc.M20362320012032153Search in Google Scholar

[39]Choi S.J., Chung S.S., Rho E.J., Lee H.W., Lee M.H., Choi H.S., Seol J.H., Baek S.H., Bang O.S., Chung C.H.: Negative modulation of RXRα transcriptional activity by small ubiquitin-related modifier (SUMO) modification and its reversal by SUMO-specific protease SUSP1. J. Biol. Chem., 2006; 281: 30669-30677Choi S.J. Chung S.S. Rho E.J. Lee H.W. Lee M.H. Choi H.S. Seol J.H. Baek S.H. Bang O.S. Chung C.H. Negative modulation of RXRα transcriptional activity by small ubiquitin-related modifier (SUMO) modification and its reversal by SUMO-specific protease SUSP1 J. Biol. Chem 2006 281 30669 3067710.1074/jbc.M60403320016912044Search in Google Scholar

[40]Sołtys K., Ożyhar A.: Ordered structure-forming properties of the intrinsically disordered AB region of hRXRγ and its ability to promote liquid-liquid phase separation. J. Steroid Biochem. Mol. Biol., 2020; 198: 105571Sołtys K. Ożyhar A. Ordered structure-forming properties of the intrinsically disordered AB region of hRXRγ and its ability to promote liquid-liquid phase separation J. Steroid Biochem. Mol. Biol 2020 198 10557110.1016/j.jsbmb.2019.10557131881311Search in Google Scholar

[41]Alberti S., Gladfelter A., Mittag T.: Considerations and challenges in studying liquid-liquid phase separation and biomolecular condensates. Cell, 2019; 176: 419-434Alberti S. Gladfelter A. Mittag T. Considerations and challenges in studying liquid-liquid phase separation and biomolecular condensates Cell 2019 176 419 43410.1016/j.cell.2018.12.035644527130682370Search in Google Scholar

[42]Alberti S., Dormann D.: Liquid-liquid phase separation in disease. Annu. Rev. Genet., 2019; 53: 171-194Alberti S. Dormann D. Liquid-liquid phase separation in disease Annu. Rev. Genet 2019 53 171 19410.1146/annurev-genet-112618-043527Search in Google Scholar

[43]Patel A., Lee H.O., Jawerth L., Maharana S., Jahnel M., Hein M.Y., Stoynov S., Mahamid J., Saha S., Franzmann T.M., Pozniakovski A., Poser I., Maghelli N., Royer L.A., Weigert M. i wsp.: A liquid-to-solid phase transition of the ALS protein FUS accelerated by disease mutation. Cell, 2015; 162: 1066-1077Patel A. Lee H.O. Jawerth L. Maharana S. Jahnel M. Hein M.Y. Stoynov S. Mahamid J. Saha S. Franzmann T.M. Pozniakovski A. Poser I. Maghelli N. Royer L.A. Weigert M. i wsp A liquid-to-solid phase transition of the ALS protein FUS accelerated by disease mutation Cell 2015 162 1066 107710.1016/j.cell.2015.07.047Search in Google Scholar

[44]Boija A., Klein I.A., Sabari B.R., Dall’Agnese A., Coffey E.L., Zamudio A.V., Li C.H., Shrinivas K., Manteiga J.C., Hannett N.M., Abraham B.J., Afeyan L.K., Guo Y.E., Rimel J.K., Fant C.B. i wsp.: Transcription factors activate genes through the phase-separation capacity of their activation domains. Cell, 2018; 175: 1842-1855. e16Boija A. Klein I.A. Sabari B.R. Dall’Agnese A. Coffey E.L. Zamudio A.V. Li C.H. Shrinivas K. Manteiga J.C. Hannett N.M. Abraham B.J. Afeyan L.K. Guo Y.E. Rimel J.K. Fant C.B. i wsp Transcription factors activate genes through the phase-separation capacity of their activation domains Cell 2018 175 1842 1855 e1610.1016/j.cell.2018.10.042Search in Google Scholar

[45]Kumar R., Johnson B.H., Thompson E.B.: Overview of the structural basis for transcription regulation by nuclear hormone receptors. Essays Biochem., 2004; 40: 27-39Kumar R. Johnson B.H. Thompson E.B. Overview of the structural basis for transcription regulation by nuclear hormone receptors Essays Biochem 2004 40 27 3910.1042/bse0400027Search in Google Scholar

[46]Gronemeyer H., Miturski R.: Molecular mechanisms of retinoid action. Cell. Mol. Biol. Lett., 2001; 6: 3-52Gronemeyer H. Miturski R. Molecular mechanisms of retinoid action Cell. Mol. Biol. Lett 2001 6 3 52Search in Google Scholar

[47]Wilson T.E., Paulsen R.E., Padgett K.A., Milbrandt J.: Participation of non-zinc finger residues in DNA binding by two nuclear orphan receptors. Science, 1992; 256: 107-110Wilson T.E. Paulsen R.E. Padgett K.A. Milbrandt J. Participation of non-zinc finger residues in DNA binding by two nuclear orphan receptors Science 1992 256 107 11010.1126/science.1314418Search in Google Scholar

[48]Zechel C., Shen X.Q., Chambon P., Gronemeyer H.: Dimerization interfaces formed between the DNA binding domains determine the cooperative binding of RXR/RAR and RXR/TR heterodimers to DR5 and DR4 elements. EMBO J., 1994; 13: 1414-1424Zechel C. Shen X.Q. Chambon P. Gronemeyer H. Dimerization interfaces formed between the DNA binding domains determine the cooperative binding of RXR/RAR and RXR/TR heterodimers to DR5 and DR4 elements EMBO J 1994 13 1414 142410.1002/j.1460-2075.1994.tb06395.xSearch in Google Scholar

[49]Zechel C., Shen X.Q., Chen J.Y., Chen Z.P., Chambon P., Gronemeyer H.: The dimerization interfaces formed between the DNA binding domains of RXR, RAR and TR determine the binding specificity and polarity of the full-length receptors to direct repeats. EMBO J., 1994; 13: 1425-1433Zechel C. Shen X.Q. Chen J.Y. Chen Z.P. Chambon P. Gronemeyer H. The dimerization interfaces formed between the DNA binding domains of RXR, RAR and TR determine the binding specificity and polarity of the full-length receptors to direct repeats EMBO J 1994 13 1425 143310.1002/j.1460-2075.1994.tb06396.xSearch in Google Scholar

[50]Black B.E., Holaska J.M., Rastinejad F., Paschal B.M.: DNA binding domains in diverse nuclear receptors function as nuclear export signals. Curr. Biol., 2001; 11: 1749-1758Black B.E. Holaska J.M. Rastinejad F. Paschal B.M. DNA binding domains in diverse nuclear receptors function as nuclear export signals Curr. Biol 2001 11 1749 175810.1016/S0960-9822(01)00537-1Search in Google Scholar

[51]Jacobs C.M., Paulsen R.E.: Crosstalk between ERK2 and RXR regulates nuclear import of transcription factor NGFI-B. Biochem. Biophys. Res. Commun., 2005; 336: 646-652Jacobs C.M. Paulsen R.E. Crosstalk between ERK2 and RXR regulates nuclear import of transcription factor NGFI-B Biochem. Biophys. Res. Commun 2005 336 646 65210.1016/j.bbrc.2005.08.14316140267Search in Google Scholar

[52]Dash A.K., Yende A.S., Jaiswal B., Tyagi R.K.: Heterodimerization of retinoid X receptor with xenobiotic receptor partners occurs in the cytoplasmic compartment: Mechanistic insights of events in living cells. Exp. Cell Res., 2017; 360: 337-346Dash A.K. Yende A.S. Jaiswal B. Tyagi R.K. Heterodimerization of retinoid X receptor with xenobiotic receptor partners occurs in the cytoplasmic compartment: Mechanistic insights of events in living cells Exp. Cell Res 2017 360 337 34610.1016/j.yexcr.2017.09.02428939253Search in Google Scholar

[53]García P., Lorenzo P., de Lera A.R.: Natural ligands of RXR receptors. In: Retinoid Signaling Pathways, ed.: E. Pohl. Academic Press, Cambridge MA 2020, 209-234García P. Lorenzo P. de Lera A.R. Natural ligands of RXR receptors In: Retinoid Signaling Pathways ed Pohl E. Academic Press Cambridge MA 2020 209 23410.1016/bs.mie.2020.02.006Search in Google Scholar

[54]Hsieh J.C., Whitfield G.K., Jurutka P.W., Haussler C.A., Thatcher M.L., Thompson P.D., Dang H.T., Galligan M.A., Oza A.K., Haussler M.R.: Two basic amino acids C-terminal of the proximal box specify functional binding of the vitamin D receptor to its rat osteocalcin deoxyribonucleic acid-responsive element. Endocrinology, 2003; 144: 5065-5080Hsieh J.C. Whitfield G.K. Jurutka P.W. Haussler C.A. Thatcher M.L. Thompson P.D. Dang H.T. Galligan M.A. Oza A.K. Haussler M.R. Two basic amino acids C-terminal of the proximal box specify functional binding of the vitamin D receptor to its rat osteocalcin deoxyribonucleic acid-responsive element Endocrinology 2003 144 5065 508010.1210/en.2003-0635Search in Google Scholar

[55]Kovalevich J., Yen W., Ozdemir A., Langford D.: Cocaine induces nuclear export and degradation of neuronal retinoid X receptor-γ via a TNF-α/JNK- mediated mechanism. J. neuroimmune Pharmacol., 2015; 10: 55-73Kovalevich J. Yen W. Ozdemir A. Langford D. Cocaine induces nuclear export and degradation of neuronal retinoid X receptor-γ via a TNF-α/JNK- mediated mechanism J. neuroimmune Pharmacol 2015 10 55 7310.1007/s11481-014-9573-xSearch in Google Scholar

[56]Zomer A.W., van Der Burg B., Jansen G.A., Wanders R.J., Poll-The B.T., van Der Saag P.T.: Pristanic acid and phytanic acid: Naturally occurring ligands for the nuclear receptor peroxisome proliferator-activated receptor α. J. Lipid Res., 2000; 41: 18011807Zomer A.W. van Der Burg B. Jansen G.A. Wanders R.J. Poll-The B.T. van Der Saag P.T. Pristanic acid and phytanic acid: Naturally occurring ligands for the nuclear receptor peroxisome proliferator-activated receptor α J. Lipid Res 2000 41 1801180710.1016/S0022-2275(20)31973-8Search in Google Scholar

[57]de Lera Á.R., Krezel W., Rühl R.: An endogenous mammalian retinoid X receptor ligand, at last! ChemMedChem, 2016; 11: 1027-1037de Lera Á.R Krezel W. Rühl R. An endogenous mammalian retinoid X receptor ligand, at last! ChemMedChem 2016 11 1027 103710.1002/cmdc.20160010527151148Search in Google Scholar

[58]Laudet V., Gronemeyer H.: The Nuclear Receptor FactsBook. Academic Press, Cambridge MA 2002Laudet V. Gronemeyer H. The Nuclear Receptor FactsBook Academic Press Cambridge MA 200210.1016/B978-012437735-6/50032-1Search in Google Scholar

[59]Bruck N., Bastien J., Bour G., Tarrade A., Plassat J.L., Bauer A., Adam-Stitah S., Rochette-Egly C.: Phosphorylation of the retinoid X receptor at the omega loop, modulates the expression of retinoic-acid-target genes with a promoter context specificity. Cell. Signal., 2005; 17: 1229-1239Bruck N. Bastien J. Bour G. Tarrade A. Plassat J.L. Bauer A. Adam-Stitah S. Rochette-Egly C. Phosphorylation of the retinoid X receptor at the omega loop, modulates the expression of retinoic-acid-target genes with a promoter context specificity Cell. Signal 2005 17 1229 123910.1016/j.cellsig.2004.12.00616038797Search in Google Scholar

[60]Germain P., Chambon P., Eichele G., Evans R.M., Lazar M.A., Leid M., De Lera A.R., Lotan R., Mangelsdorf D.J., Gronemeyer H.: International Union of Pharmacology. LXIII. Retinoid X receptors. Pharmacol. Rev., 2006; 58: 760-772Germain P. Chambon P. Eichele G. Evans R.M. Lazar M.A. Leid M. De Lera A.R. Lotan R. Mangelsdorf D.J. Gronemeyer H. International Union of Pharmacology. LXIII. Retinoid X receptors Pharmacol. Rev 2006 58 760 77210.1124/pr.58.4.717132853Search in Google Scholar

[61]Bastien J., Rochette-Egly C.: Nuclear retinoid receptors and the transcription of retinoid-target genes. Gene, 2004; 328: 1-16Bastien J. Rochette-Egly C. Nuclear retinoid receptors and the transcription of retinoid-target genes Gene 2004 328 1 1610.1016/j.gene.2003.12.00515019979Search in Google Scholar

[62]de Almeida N.R., Conda-Sheridan M.: A review of the molecular design and biological activities of RXR agonists. Med. Res. Rev., 2019; 39: 1372-1397de Almeida N.R. Conda-Sheridan M. A review of the molecular design and biological activities of RXR agonists Med. Res. Rev 2019 39 1372 139710.1002/med.21578656547930941786Search in Google Scholar

[63]Kojetin D.J., Matta-Camacho E., Hughes T.S., Srinivasan S., Nwachukwu J.C., Cavett V., Nowak J., Chalmers M.J., Marciano D.P., Kamenecka T.M., Shulman A.I., Rance M., Griffin P.R., Bruning J.B., Nettles K.W.: Structural mechanism for signal transduction in RXR nuclear receptor heterodimers. Nat. Commun., 2015; 6: 8013Kojetin D.J. Matta-Camacho E. Hughes T.S. Srinivasan S. Nwachukwu J.C. Cavett V. Nowak J. Chalmers M.J. Marciano D.P. Kamenecka T.M. Shulman A.I. Rance M. Griffin P.R. Bruning J.B. Nettles K.W. Structural mechanism for signal transduction in RXR nuclear receptor heterodimers Nat. Commun 2015 6 801310.1038/ncomms9013Search in Google Scholar

[64]Lee H.Y., Suh Y.A., Robinson M.J., Clifford J.L., Hong W.K., Woodgett J.R., Cobb M.H., Mangelsdorf D.J., Kurie J.M.: Stress pathway activation induces phosphorylation of retinoid X receptor. J. Biol. Chem., 2000; 275: 32193-32199Lee H.Y. Suh Y.A. Robinson M.J. Clifford J.L. Hong W.K. Woodgett J.R. Cobb M.H. Mangelsdorf D.J. Kurie J.M. Stress pathway activation induces phosphorylation of retinoid X receptor J. Biol. Chem 2000 275 32193 3219910.1074/jbc.M005490200Search in Google Scholar

[65]Cao X., Liu W., Lin F., Li H., Kolluri S.K., Lin B., Han Y.H., Dawson M.I., Zhang X.K.: Retinoid X receptor regulates Nur77/TR3-dependent apoptosis [corrected] by modulating its nuclear export and mitochondrial targeting. Mol. Cell. Biol., 2004; 24: 9705-9725Cao X. Liu W. Lin F. Li H. Kolluri S.K. Lin B. Han Y.H. Dawson M.I. Zhang X.K. Retinoid X receptor regulates Nur77/TR3-dependent apoptosis [corrected] by modulating its nuclear export and mitochondrial targeting Mol. Cell. Biol 2004 24 9705 972510.1128/MCB.24.22.9705-9725.2004Search in Google Scholar

[66]Matsushima-Nishiwaki R., Okuno M., Adachi S., Sano T., Akita K., Moriwaki H., Friedman S.L., Kojima S.: Phosphorylation of retinoid X receptor alpha at serine 260 impairs its metabolism and function in human hepatocellular carcinoma. Cancer Res., 2001; 61: 7675-7682Matsushima-Nishiwaki R. Okuno M. Adachi S. Sano T. Akita K. Moriwaki H. Friedman S.L. Kojima S. Phosphorylation of retinoid X receptor alpha at serine 260 impairs its metabolism and function in human hepatocellular carcinoma Cancer Res 2001 61 7675 7682Search in Google Scholar

[67]Solomon C., White J.H., Kremer R.: Mitogen-activated protein kinase inhibits 1,25-dihydroxyvitamin D³-dependent signal transduction by phosphorylating human retinoid X receptor α. J. Clin. Invest., 1999; 103: 1729-1735Solomon C. White J.H. Kremer R. Mitogen-activated protein kinase inhibits 1,25-dihydroxyvitamin D³-dependent signal transduction by phosphorylating human retinoid X receptor α J. Clin. Invest 1999 103 1729 173510.1172/JCI6871Search in Google Scholar

[68]Glass C.K.: Differential recognition of target genes by nuclear receptor monomers, dimers, and heterodimers. Endocr. Rev., 1994; 15: 391-407Glass C.K. Differential recognition of target genes by nuclear receptor monomers, dimers, and heterodimers Endocr. Rev 1994 15 391 40710.1210/edrv-15-3-391Search in Google Scholar

[69]Rosenfeld M.G., Glass C.K.: Coregulator codes of transcriptional regulation by nuclear receptors. J. Biol. Chem., 2001; 276: 3686536868Rosenfeld M.G. Glass C.K. Coregulator codes of transcriptional regulation by nuclear receptors J. Biol. Chem 2001 276 368653686810.1074/jbc.R100041200Search in Google Scholar

[70]Perissi V., Staszewski L.M., McInerney E.M., Kurokawa R., Krones A., Rose D.W., Lambert M.H., Milburn M.V., Glass C.K., Rosenfeld M.G.: Molecular determinants of nuclear receptor-corepressor interaction. Genes Dev., 1999; 13: 3198-3208Perissi V. Staszewski L.M. McInerney E.M. Kurokawa R. Krones A. Rose D.W. Lambert M.H. Milburn M.V. Glass C.K. Rosenfeld M.G. Molecular determinants of nuclear receptor-corepressor interaction Genes Dev 1999 13 3198 320810.1101/gad.13.24.3198Search in Google Scholar

[71]Wolffe A.P., Pruss D.: Targeting chromatin disruption: Transcription regulators that acetylate histones. Cell, 1996; 84: 817-819Wolffe A.P. Pruss D. Targeting chromatin disruption: Transcription regulators that acetylate histones Cell 1996 84 817 81910.1016/S0092-8674(00)81059-4Search in Google Scholar

[72]Shulman A.I., Mangelsdorf D.J.: Retinoid X receptor heterodimers in the metabolic syndrome. N. Engl. J. Med., 2005; 353: 604-615Shulman A.I. Mangelsdorf D.J. Retinoid X receptor heterodimers in the metabolic syndrome N. Engl. J. Med 2005 353 604 61510.1056/NEJMra04359016093469Search in Google Scholar

[73]Heery D.M., Kalkhoven E., Hoare S., Parker M.G.: A signature motif in transcriptional co-activators mediates binding to nuclear receptors. Nature, 1997; 387: 733-736Heery D.M. Kalkhoven E. Hoare S. Parker M.G. A signature motif in transcriptional co-activators mediates binding to nuclear receptors Nature 1997 387 733 73610.1038/427509192902Search in Google Scholar

[74]Krężel W., Rühl R., de Lera A.R.: Alternative retinoid X receptor (RXR) ligands. Mol. Cell. Endocrinol., 2019; 491: 110436Krężel W. Rühl R. de Lera A.R. Alternative retinoid X receptor (RXR) ligands Mol. Cell. Endocrinol 2019 491 11043610.1016/j.mce.2019.04.01631026478Search in Google Scholar

[75]Arnold S.L., Amory J.K., Walsh T.J., Isoherranen N.: A sensitive and specific method for measurement of multiple retinoids in human serum with UHPLC-MS/MS. J. Lipid Res., 2012; 53: 587-598Arnold S.L. Amory J.K. Walsh T.J. Isoherranen N. A sensitive and specific method for measurement of multiple retinoids in human serum with UHPLC-MS/MS J. Lipid Res 2012 53 587 59810.1194/jlr.D019745327648322192917Search in Google Scholar

[76]Cheng C., Michaels J., Scheinfeld N.: Alitretinoin: A comprehensive review. Expert Opin. Investig. Drugs, 2008; 17: 437-443Cheng C. Michaels J. Scheinfeld N. Alitretinoin: A comprehensive review Expert Opin. Investig. Drugs 2008 17 437 44310.1517/13543784.17.3.43718321241Search in Google Scholar

[77]de Urquiza A.M., Liu S., Sjöberg M., Zetterström R.H., Griffiths W., Sjövall J., Perlmann T.: Docosahexaenoic acid, a ligand for the retinoid X receptor in mouse brain. Science, 2000; 290: 2140-2144de Urquiza A.M. Liu S. Sjöberg M. Zetterström R.H. Griffiths W. Sjövall J. Perlmann T. Docosahexaenoic acid, a ligand for the retinoid X receptor in mouse brain Science 2000 290 2140 214410.1126/science.290.5499.214011118147Search in Google Scholar

[78]Lengqvist J., Mata De Urquiza A., Bergman A.C., Willson T.M., Sjövall J., Perlmann T., Griffiths W.J.: Polyunsaturated fatty acids including docosahexaenoic and arachidonic acid bind to the retinoid X receptor alpha ligand-binding domain. Mol. Cell. Proteomics, 2004; 3: 692-703Lengqvist J. Mata De Urquiza A. Bergman A.C. Willson T.M. Sjövall J. Perlmann T. Griffiths W.J. Polyunsaturated fatty acids including docosahexaenoic and arachidonic acid bind to the retinoid X receptor alpha ligand-binding domain Mol. Cell. Proteomics 2004 3 692 70310.1074/mcp.M400003-MCP20015073272Search in Google Scholar

[79]Mic F.A., Molotkov A., Benbrook D.M., Duester G.: Retinoid activation of retinoic acid receptor but not retinoid X receptor is sufficient to rescue lethal defect in retinoic acid synthesis. Proc. Natl. Acad. Sci. USA, 2003; 100: 7135-7140Mic F.A. Molotkov A. Benbrook D.M. Duester G. Retinoid activation of retinoic acid receptor but not retinoid X receptor is sufficient to rescue lethal defect in retinoic acid synthesis Proc. Natl. Acad. Sci. USA 2003 100 7135 714010.1073/pnas.123142210016584212782789Search in Google Scholar

[80]Wallen-Mackenzie A., Mata de Urquiza A., Petersson S., Rodriguez F.J., Friling S., Wagner J., Ordentlich P., Lengqvist J., Heyman R.A., Arenas E., Perlmann T.: Nurr1-RXR heterodimers mediate RXR ligand-induced signaling in neuronal cells. Genes Dev., 2003; 17: 3036-3047Wallen-Mackenzie A. Mata de Urquiza A. Petersson S. Rodriguez F.J. Friling S. Wagner J. Ordentlich P. Lengqvist J. Heyman R.A. Arenas E. Perlmann T. Nurr1-RXR heterodimers mediate RXR ligand-induced signaling in neuronal cells Genes Dev 2003 17 3036 304710.1101/gad.27600330525614681209Search in Google Scholar

[81]Wietrzych-Schindler M., Szyszka-Niagolov M., Ohta K., Endo Y., Pérez E., de Lera A.R., Chambon P., Krezel W.: Retinoid X receptor gamma is implicated in docosahexaenoic acid modulation of despair behaviors and working memory in mice. Biol. Psychiatry, 2011; 69: 788-794Wietrzych-Schindler M. Szyszka-Niagolov M. Ohta K. Endo Y. Pérez E. de Lera A.R. Chambon P. Krezel W. Retinoid X receptor gamma is implicated in docosahexaenoic acid modulation of despair behaviors and working memory in mice Biol. Psychiatry 2011 69 788 79410.1016/j.biopsych.2010.12.01721334601Search in Google Scholar

[82]Lo Van A., Sakayori N., Hachem M., Belkouch M., Picq M., Lagarde M., Osumi N., Bernoud-Hubac N.: Mechanisms of DHA transport to the brain and potential therapy to neurodegenerative diseases. Biochimie, 2016; 130: 163-167Lo Van A. Sakayori N. Hachem M. Belkouch M. Picq M. Lagarde M. Osumi N. Bernoud-Hubac N. Mechanisms of DHA transport to the brain and potential therapy to neurodegenerative diseases Biochimie 2016 130 163 16710.1016/j.biochi.2016.07.01127496085Search in Google Scholar

[83]Lemotte P.K., Keidel S., Apfel C.M.: Phytanic acid is a retinoid X receptor ligand. Eur. J. Biochem., 1996; 236: 328-333Lemotte P.K. Keidel S. Apfel C.M. Phytanic acid is a retinoid X receptor ligand Eur. J. Biochem 1996 236 328 33310.1111/j.1432-1033.1996.00328.x8617282Search in Google Scholar

[84]Rühl R., Krzyżosiak A., Niewiadomska-Cimicka A., Rochel N., Széles L., Vaz B., Wietrzych-Schindler M., Álvarez S., Szklenár M., Nagy L., de Lera A.R., Krężel W.: 9-cis-13,14-dihydroretinoic acid is an endogenous retinoid acting as RXR ligand in mice. PLOS Genet., 2015; 11: e1005213Rühl R. Krzyżosiak A. Niewiadomska-Cimicka A. Rochel N. Széles L. Vaz B. Wietrzych-Schindler M. Álvarez S. Szklenár M. Nagy L. de Lera A.R. Krężel W. 9-cis-13,14-dihydroretinoic acid is an endogenous retinoid acting as RXR ligand in mice PLOS Genet 2015 11 e100521310.1371/journal.pgen.1005213Search in Google Scholar

[85]Harmon M.A., Boehm M.F., Heyman R.A., Mangelsdorf D.J.: Activation of mammalian retinoid X receptors by the insect growth regulator methoprene. Proc. Natl. Acad. Sci. USA, 1995; 92: 61576160Harmon M.A. Boehm M.F. Heyman R.A. Mangelsdorf D.J. Activation of mammalian retinoid X receptors by the insect growth regulator methoprene Proc. Natl. Acad. Sci. USA 1995 92 6157616010.1073/pnas.92.13.6157Search in Google Scholar

[86]Hiebl V., Ladurner A., Latkolik S., Dirsch V.M.: Natural products as modulators of the nuclear receptors and metabolic sensors LXR, FXR and RXR. Biotechnol. Adv., 2018; 36: 1657-1698Hiebl V. Ladurner A. Latkolik S. Dirsch V.M. Natural products as modulators of the nuclear receptors and metabolic sensors LXR, FXR and RXR Biotechnol. Adv 2018 36 1657 169810.1016/j.biotechadv.2018.03.003Search in Google Scholar

[87]Shen D., Yu X., Wu Y., Chen Y., Li G., Cheng F., Xia L.: Emerging roles of bexarotene in the prevention, treatment and anti-drug resistance of cancers. Expert Rev. Anticancer Ther., 2018; 18: 487-499Shen D. Yu X. Wu Y. Chen Y. Li G. Cheng F. Xia L. Emerging roles of bexarotene in the prevention, treatment and anti-drug resistance of cancers Expert Rev. Anticancer Ther 2018 18 487 49910.1080/14737140.2018.1449648Search in Google Scholar

[88]Tousi B.: The emerging role of bexarotene in the treatment of Alzheimer’s disease: Current evidence. Neuropsychiatr. Dis. Treat., 2015; 11: 311-315Tousi B. The emerging role of bexarotene in the treatment of Alzheimer’s disease: Current evidence Neuropsychiatr. Dis. Treat 2015 11 311 31510.2147/NDT.S61309Search in Google Scholar

[89]Szanto A., Narkar V., Shen Q., Uray I.P., Davies P.J.A., Nagy L.: Retinoid X receptors: X-ploring their (patho)physiological functions. Cell Death Differ., 2004; 11: 126-143Szanto A. Narkar V. Shen Q. Uray I.P. Davies P.J.A. Nagy L. Retinoid X receptors: X-ploring their (patho)physiological functions Cell Death Differ 2004 11 126 14310.1038/sj.cdd.4401533Search in Google Scholar

[90]Wan Y.J., An D., Cai Y., Repa J.J., Hung-Po Chen T., Flores M., Postic C., Magnuson M.A., Chen J., Chien K.R., French S., Mangelsdorf D.J., Sucov H.M.: Hepatocyte-specific mutation establishes retinoid X receptor α as a heterodimeric integrator of multiple physiological processes in the liver. Mol. Cell. Biol., 2000; 20: 4436-4444Wan Y.J. An D. Cai Y. Repa J.J. Hung-Po Chen T. Flores M. Postic C. Magnuson M.A. Chen J. Chien K.R. French S. Mangelsdorf D.J. Sucov H.M. Hepatocyte-specific mutation establishes retinoid X receptor α as a heterodimeric integrator of multiple physiological processes in the liver Mol. Cell. Biol 2000 20 4436 444410.1128/MCB.20.12.4436-4444.2000Search in Google Scholar

[91]Lu T.T., Repa J.J., Mangelsdorf D.J.: Orphan nuclear receptors as eLiXiRs and FiXeRs of sterol metabolism. J. Biol. Chem., 2001; 276: 37735-37738Lu T.T. Repa J.J. Mangelsdorf D.J. Orphan nuclear receptors as eLiXiRs and FiXeRs of sterol metabolism J. Biol. Chem 2001 276 37735 3773810.1074/jbc.R100035200Search in Google Scholar

[92]Lu T.T., Makishima M., Repa J.J., Schoonjans K., Kerr T.A., Auwerx J., Mangelsdorf D.J.: Molecular basis for feedback regulation of bile acid synthesis by nuclear receptors. Mol. Cell, 2000; 6: 507-515Lu T.T. Makishima M. Repa J.J. Schoonjans K. Kerr T.A. Auwerx J. Mangelsdorf D.J. Molecular basis for feedback regulation of bile acid synthesis by nuclear receptors Mol. Cell 2000 6 507 51510.1016/S1097-2765(00)00050-2Search in Google Scholar

[93]Repa J.J., Turley S.D., Lobaccaro J.A., Medina J., Li L., Lustig K., Shan B., Heyman R.A., Dietschy J.M., Mangelsdorf D.J.: Regulation of absorption and ABC1-mediated efflux of cholesterol by RXR heterodimers. Science, 2000; 289: 1524-1529Repa J.J. Turley S.D. Lobaccaro J.A. Medina J. Li L. Lustig K. Shan B. Heyman R.A. Dietschy J.M. Mangelsdorf D.J. Regulation of absorption and ABC1-mediated efflux of cholesterol by RXR heterodimers Science 2000 289 1524 152910.1126/science.289.5484.152410968783Search in Google Scholar

[94]Picard F., Auwerx J.: PPARγ and glucose homeostasis. Annu. Rev. Nutr., 2002; 22: 167-197Picard F. Auwerx J. PPARγ and glucose homeostasis Annu. Rev. Nutr 2002 22 167 19710.1146/annurev.nutr.22.010402.102808Search in Google Scholar

[95]Dobrzyn P., Dobrzyn A., Miyazaki M., Cohen P., Asilmaz E., Hardie D.G., Friedman J.M., Ntambi J.M.: Stearoyl-CoA desaturase 1 deficiency increases fatty acid oxidation by activating AMP-activated protein kinase in liver. Proc. Natl. Acad. Sci. USA, 2004; 101: 6409-6414Dobrzyn P. Dobrzyn A. Miyazaki M. Cohen P. Asilmaz E. Hardie D.G. Friedman J.M. Ntambi J.M. Stearoyl-CoA desaturase 1 deficiency increases fatty acid oxidation by activating AMP-activated protein kinase in liver Proc. Natl. Acad. Sci. USA 2004 101 6409 641410.1073/pnas.0401627101Search in Google Scholar

[96]Dziewulska A., Dobosz A.M., Dobrzyn A., Smolinska A., Kolczynska K., Ntambi J.M., Dobrzyn P.: SCD1 regulates the AMPK/ SIRT1 pathway and histone acetylation through changes in adenine nucleotide metabolism in skeletal muscle. J. Cell. Physiol., 2020; 235: 1129-1140Dziewulska A. Dobosz A.M. Dobrzyn A. Smolinska A. Kolczynska K. Ntambi J.M. Dobrzyn P. SCD1 regulates the AMPK/ SIRT1 pathway and histone acetylation through changes in adenine nucleotide metabolism in skeletal muscle J. Cell. Physiol 2020 235 1129 114010.1002/jcp.29026Search in Google Scholar

[97]Chang S.C., Rashid A., Gao Y.T., Andreotti G., Shen M.C., Wang B.S., Han T.Q., Zhang B.H., Sakoda L.C., Leitzmann M.F., Chen B.E., Rosenberg P.S., Chen J., Chanock S.J., Hsing A.W.: Polymorphism of genes related to insulin sensitivity and the risk of biliary tract cancer and biliary stone: A population-based case-control study in Shanghai, China. Carcinogenesis, 2008; 29: 944-948Chang S.C. Rashid A. Gao Y.T. Andreotti G. Shen M.C. Wang B.S. Han T.Q. Zhang B.H. Sakoda L.C. Leitzmann M.F. Chen B.E. Rosenberg P.S. Chen J. Chanock S.J. Hsing A.W. Polymorphism of genes related to insulin sensitivity and the risk of biliary tract cancer and biliary stone: A population-based case-control study in Shanghai, China Carcinogenesis 2008 29 944 94810.1093/carcin/bgn025Search in Google Scholar

[98]Wang H., Chu W., Hemphill C., Hasstedt S.J., Elbein S.C.: Mutation screening and association of human retinoid X receptor γ variation with lipid levels in familial type 2 diabetes. Mol. Genet. Metab., 2002; 76: 14-22Wang H. Chu W. Hemphill C. Hasstedt S.J. Elbein S.C. Mutation screening and association of human retinoid X receptor γ variation with lipid levels in familial type 2 diabetes Mol. Genet. Metab 2002 76 14 2210.1016/S1096-7192(02)00016-1Search in Google Scholar

[99]Nohara A., Kawashiri M.A., Claudel T., Mizuno M., Tsuchida M., Takata M., Katsuda S., Miwa K., Inazu A., Kuipers F., Kobayashi J., Koizumi J., Yamagishi M., Mabuchi H.: High frequency of a retinoid X receptor γ gene variant in familial combined hyperlipidemia that associates with atherogenic dyslipidemia. Arterioscler. Thromb. Vasc. Biol., 2007; 27: 923-928Nohara A. Kawashiri M.A. Claudel T. Mizuno M. Tsuchida M. Takata M. Katsuda S. Miwa K. Inazu A. Kuipers F. Kobayashi J. Koizumi J. Yamagishi M. Mabuchi H. High frequency of a retinoid X receptor γ gene variant in familial combined hyperlipidemia that associates with atherogenic dyslipidemia Arterioscler. Thromb. Vasc. Biol 2007 27 923 92810.1161/01.ATV.0000258945.76141.8aSearch in Google Scholar

[100]Shi H., Yu X., Li Q., Ye X., Gao Y., Ma J., Cheng J., Lu Y., Du W., Du J., Ye Q., Zhao X., Zhou L.: Association between PPAR-γ and RXR-α gene polymorphism and metabolic syndrome risk: A case-control study of a Chinese Han population. Arch. Med. Res., 2012; 43: 233-242Shi H. Yu X. Li Q. Ye X. Gao Y. Ma J. Cheng J. Lu Y. Du W. Du J. Ye Q. Zhao X. Zhou L. Association between PPAR-γ and RXR-α gene polymorphism and metabolic syndrome risk: A case-control study of a Chinese Han population Arch. Med. Res 2012 43 233 24210.1016/j.arcmed.2012.03.006Search in Google Scholar

[101]Baldassarro V.A., Krężel W., Fernández M., Schuhbaur B., Giardino L., Calzà L.: The role of nuclear receptors in the differentiation of oligodendrocyte precursor cells derived from fetal and adult neural stem cells. Stem Cell Res., 2019; 37: 101443Baldassarro V.A. Krężel W. Fernández M. Schuhbaur B. Giardino L. Calzà L. The role of nuclear receptors in the differentiation of oligodendrocyte precursor cells derived from fetal and adult neural stem cells Stem Cell Res 2019 37 10144310.1016/j.scr.2019.101443Search in Google Scholar

[102]Chiang M.Y., Misner D., Kempermann G., Schikorski T., Giguère V., Sucov H.M., Gage F.H., Stevens C.F., Evans R.M.: An essential role for retinoid receptors RARβ and RXRγ in longterm potentiation and depression. Neuron, 1998; 21: 1353-1361Chiang M.Y. Misner D. Kempermann G. Schikorski T. Giguère V. Sucov H.M. Gage F.H. Stevens C.F. Evans R.M. An essential role for retinoid receptors RARβ and RXRγ in longterm potentiation and depression Neuron 1998 21 1353 136110.1016/S0896-6273(00)80654-6Search in Google Scholar

[103]Huang J.K., Jarjour A.A., Nait Oumesmar B., Kerninon C., Williams A., Krezel W., Kagechika H., Bauer J., Zhao C., Baron-Van Evercooren A., Chambon P., Ffrench-Constant C., Franklin R.J.: Retinoid X receptor gamma signaling accelerates CNS remyelination. Nat. Neurosci., 2011; 14: 45-53Huang J.K. Jarjour A.A. Nait Oumesmar B. Kerninon C. Williams A. Krezel W. Kagechika H. Bauer J. Zhao C. Baron-Van Evercooren A. Chambon P. Ffrench-Constant C. Franklin R.J. Retinoid X receptor gamma signaling accelerates CNS remyelination Nat. Neurosci 2011 14 45 5310.1038/nn.2702401350821131950Search in Google Scholar

[104]Tanaka T., Dancheck B.L., Trifiletti L.C., Birnkrant R.E., Taylor B.J., Garfield S.H., Thorgeirsson U., De Luca L.M.: Altered localization of retinoid X receptor α coincides with loss of retinoid responsiveness in human breast cancer MDA-MB-231 cells. Mol. Cell. Biol., 2004; 24: 3972-3982Tanaka T. Dancheck B.L. Trifiletti L.C. Birnkrant R.E. Taylor B.J. Garfield S.H. Thorgeirsson U. De Luca L.M. Altered localization of retinoid X receptor α coincides with loss of retinoid responsiveness in human breast cancer MDA-MB-231 cells Mol. Cell. Biol 2004 24 3972 398210.1128/MCB.24.9.3972-3982.200438773415082790Search in Google Scholar

[105]Zhong C., Yang S., Huang J., Cohen M.B., Roy-Burman P.: Aberration in the expression of the retinoid receptor, RXRα, in prostate cancer. Cancer Biol. Ther., 2003; 2: 179-184Zhong C. Yang S. Huang J. Cohen M.B. Roy-Burman P. Aberration in the expression of the retinoid receptor, RXRα, in prostate cancer Cancer Biol. Ther 2003 2 179 18410.4161/cbt.2.2.28112750559Search in Google Scholar

[106]Crowe D.L., Chandraratna R.A.: A retinoid X receptor (RXR)-selective retinoid reveals that RXR-α is potentially a therapeutic target in breast cancer cell lines, and that it potentiates antiproliferative and apoptotic responses to peroxisome proliferator-activated receptor ligands. Breast Cancer Res., 2004; 6: R546-R555Crowe D.L. Chandraratna R.A. A retinoid X receptor (RXR)-selective retinoid reveals that RXR-α is potentially a therapeutic target in breast cancer cell lines, and that it potentiates antiproliferative and apoptotic responses to peroxisome proliferator-activated receptor ligands Breast Cancer Res 2004 6 R546 R55510.1186/bcr91354917415318936Search in Google Scholar

[107]Ando N., Shimizu M., Okuno M., Matsushima-Nishiwaki R., Tsurumi H., Tanaka T., Moriwaki H.: Expression of retinoid X receptor alpha is decreased in 3’-methyl-4-dimethylaminoazobenzene-induced hepatocellular carcinoma in rats. Oncol. Rep., 2007; 18: 879-884Ando N. Shimizu M. Okuno M. Matsushima-Nishiwaki R. Tsurumi H. Tanaka T. Moriwaki H. Expression of retinoid X receptor alpha is decreased in 3’-methyl-4-dimethylaminoazobenzene-induced hepatocellular carcinoma in rats Oncol. Rep 2007 18 879 88410.3892/or.18.4.879Search in Google Scholar

[108]Takiyama Y., Miyokawa N., Sugawara A., Kato S., Ito K., Sato K., Oikawa K., Kobayashi H., Kimura S., Tateno M.: Decreased expression of retinoid X receptor isoforms in human thyroid carcinomas. J. Clin. Endocrinol. Metab., 2004; 89: 5851-5861Takiyama Y. Miyokawa N. Sugawara A. Kato S. Ito K. Sato K. Oikawa K. Kobayashi H. Kimura S. Tateno M. Decreased expression of retinoid X receptor isoforms in human thyroid carcinomas J. Clin. Endocrinol. Metab 2004 89 5851 586110.1210/jc.2003-03203615531552Search in Google Scholar

[109]Huang G.L., Zhang W., Ren H.Y., Shen X.Y., Chen Q.X., Shen D.Y.: Retinoid X receptor α enhances human cholangiocarcinoma growth through simultaneous activation of Wnt/β-catenin and nuclear factor-κB pathways. Cancer Sci., 2015; 106: 1515-1523Huang G.L. Zhang W. Ren H.Y. Shen X.Y. Chen Q.X. Shen D.Y. Retinoid X receptor α enhances human cholangiocarcinoma growth through simultaneous activation of Wnt/β-catenin and nuclear factor-κB pathways Cancer Sci 2015 106 1515 152310.1111/cas.12802471469726310932Search in Google Scholar

[110]Zhu J., Nasr R., Pérès L., Riaucoux-Lormière F., Honoré N., Berthier C., Kamashev D., Zhou J., Vitoux D., Lavau C., de Thé H.: RXR is an essential component of the oncogenic PML/RARA complex in vivo. Cancer Cell, 2007; 12: 23-35Zhu J. Nasr R. Pérès L. Riaucoux-Lormière F. Honoré N. Berthier C. Kamashev D. Zhou J. Vitoux D. Lavau C. de Thé H. RXR is an essential component of the oncogenic PML/RARA complex in vivo Cancer Cell 2007 12 23 3510.1016/j.ccr.2007.06.00417613434Search in Google Scholar

[111]Zhang X., Zhou H., Su Y.: Targeting truncated RXRα for cancer therapy. Acta Biochim. Biophys. Sin., 2016; 48: 49-59Zhang X. Zhou H. Su Y. Targeting truncated RXRα for cancer therapy Acta Biochim. Biophys. Sin 2016 48 49 5910.1093/abbs/gmv104468915826494413Search in Google Scholar

[112]Zhou H., Liu W., Su Y., Wei Z., Liu J., Kolluri S.K., Wu H., Cao Y., Chen J., Wu Y., Yan T., Cao X., Gao W., Molotkov A., Jiang F. i wsp.: NSAID sulindac and its analog bind RXRα and inhibit RXRα-dependent AKT signaling. Cancer Cell, 2010; 17: 560-573Zhou H. Liu W. Su Y. Wei Z. Liu J. Kolluri S.K. Wu H. Cao Y. Chen J. Wu Y. Yan T. Cao X. Gao W. Molotkov A. Jiang F. i wsp NSAID sulindac and its analog bind RXRα and inhibit RXRα-dependent AKT signaling Cancer Cell 2010 17 560 57310.1016/j.ccr.2010.04.023290792120541701Search in Google Scholar